FLOMAX 0.4 MG
TAMSULOSIN HYDROCHLORIDE : 0.4 MG · DIN 02238123 · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Health Canada status: CANCELLED POST MARKET
What is FLOMAX?
FLOMAX 0.4 MG contains TAMSULOSIN HYDROCHLORIDE : 0.4 MG. It is listed in the Health Canada Drug Product Database under DIN 02238123, held by BOEHRINGER INGELHEIM (CANADA) LTD LTEE, supplied as CAPSULE (SUSTAINED-RELEASE) for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 27-Aug-2009. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02238123 |
|---|---|
| Brand name | FLOMAX |
| Generic / active ingredient | TAMSULOSIN HYDROCHLORIDE : 0.4 MG |
| Manufacturer | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
| Strength | 0.4 MG |
| Dosage form | CAPSULE (SUSTAINED-RELEASE) |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | G04CA02 TAMSULOSIN |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 27-Aug-2009 |
What can be used instead?
Other Canadian products sharing ATC code G04CA02 TAMSULOSIN. 9 of 18 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-TAMSULOSIN CR | 0.4 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED | DIN 02362406 |
| AURO-TAMSULOSIN CR | 0.4 MG | TABLET (EXTENDED-RELEASE) | AURO PHARMA INC | MARKETED | DIN 02545179 |
| JAMP TAMSULOSIN | 0.4 MG | CAPSULE (SUSTAINED-RELEASE) | JAMP PHARMA CORPORATION | MARKETED | DIN 02352419 |
| SANDOZ TAMSULOSIN | 0.4 MG | CAPSULE (SUSTAINED-RELEASE) | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02319217 |
| SANDOZ TAMSULOSIN CR | 0.4 MG | TABLET (EXTENDED-RELEASE) | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02340208 |
| TAMSULOSIN CR | 0.4 MG | TABLET (EXTENDED-RELEASE) | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02429667 |
| TAMSULOSIN CR | 0.4 MG | TABLET (EXTENDED-RELEASE) | SANIS HEALTH INC | MARKETED | DIN 02427117 |
| TAMSULOSIN CR | 0.4 MG | TABLET (EXTENDED-RELEASE) | PRO DOC LIMITEE | MARKETED | DIN 02413612 |
| TEVA-TAMSULOSIN CR | 0.4 MG | TABLET (EXTENDED-RELEASE) | TEVA CANADA LIMITED | MARKETED | DIN 02368242 |
| AVA-TAMSULOSIN CR | 0.4 MG | TABLET (EXTENDED-RELEASE) | AVANSTRA INC | CANCELLED POST MARKET | DIN 02366231 |
Who else supplies TAMSULOSIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. TAMSULOSIN appears in 192 registered pack listings across 11 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.